Aditxt, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Aditxt, Inc. (ADTX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $89.72 thousand as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-05-20
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $89.72K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $137.85K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $32.13K.
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $24.28K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-03-31 | $89.72K 10-Q · filed 2026-05-20 |
| 2025-12-31 | $137.85K 10-K · filed 2026-03-31 |
| 2025-09-30 | $32.13K 10-Q · filed 2025-11-18 |
| 2025-06-30 | $24.28K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $5.44K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $14.77K 10-K · filed 2025-03-31 |
| 2024-09-30 | $38.02K 10-Q · filed 2024-11-18 |
| 2024-06-30 | $33.66K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $60.50K 10-Q · filed 2024-05-20 |
| 2023-12-31 | $97.77K 10-K · filed 2024-04-16 |
| 2023-09-30 | $140.19K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $188.05K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $241.33K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $297.44K 10-K · filed 2023-04-17 |
| 2021-03-31 | $157.79K 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |